Reminded Investors

 
News Articles for Reminded Investors top ^
2014/11/4
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G025413-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/3/11G025413/convertedPNGlogo-121646504.jpg SAN FRANCISCO, CA--(Marketwired - November 04, 2014) - Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds investors of the upcoming November 17, 2014 deadline to file for lead plaintiff in the securities fraud class action against Lumber Liquidators Holdings, Inc. (NYSE: LL) ("Lumber Liquidators" or "the Company"). The complaint has been filed on behalf of investors who purchased Lumber Liquidators securities between November 25, 2013 and July 9, 2014 (the "Class Period"). Hagens Berman is also investigating expanding the class period to include investors who purchased through October 22, 2014 in light of newly reported developments at the company.
Sign-up for Hagens Berman Reminds Investors of November 17, 2014 Lead Plaintiff Deadline in Class-Action Against Lumber Liquidators Holdings, Inc. investment picks
Glancy Binkow & Goldberg LLP reminds investors of the November 17, 2014 deadline to move for appointment as lead plaintiff in the securities class action litigation on behalf of Bankrate, Inc. securities investors (“Bankrate” or the “Company”) (NYSE:RATE) between March 1, 2013 and September 15, 2014, inclusive (the “Class Period”). Bankrate is a leading publisher, aggregator and distributor of personal finance content on the Internet.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline In The Class Action Lawsuit Against Bankrate, Inc. investment picks
Glancy Binkow & Goldberg LLP reminds investors of MOL Global, Inc. (“MOL Global” or the “Company”) (NASDAQ:MOLG) that purchasers of MOL Global American Depositary Shares between October 9, 2014 and November 20, 2014, inclusive (the “Class Period”), including purchasers pursuant and/or traceable to the Company’s October 9, 2014 initial public offering (“IPO”), have until January 23, 2015, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Southern District of New York.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against MOL Global, Inc. investment picks
Glancy Binkow & Goldberg LLP reminds investors of Jumei International Holding Limited (“Jumei” or the “Company”) (NYSE:JMEI) that purchasers of Jumei securities pursuant and/or traceable to the Registration Statement and Prospectus issued in connection with the Company’s initial public offering on or about May 16, 2014, and/or purchasers on the open market between May 16, 2014 and November 20, 2014, have until February 10, 2015, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Southern District of New York.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Jumei International Holding Limited investment picks
The Wagner Firm reminds investors of MOL Global, Inc. (“MOL Global” or the “Company”) (NASDAQ:MOLG) that purchasers of MOL Global American Depositary Shares between October 9, 2014 and November 20, 2014, inclusive (the “Class Period”), including purchasers pursuant and/or traceable to the Company’s October 9, 2014 initial public offering (“IPO”), have until January 23, 2015, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Southern District of New York.
Sign-up for INVESTOR ALERT: The Wagner Firm Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against MOL Global, Inc. investment picks
Glancy Binkow & Goldberg LLP reminds investors of Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ:SRPT) that purchasers of Sarepta securities between April 21, 2014 and October 27, 2014, inclusive (the “Class Period”), have until February 6, 2015, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the District of Massachusetts.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Sarepta Therapeutics, Inc. investment picks
Glancy Binkow & Goldberg LLP reminds investors of FireEye, Inc. (“FireEye” or the “Company”) (NASDAQ:FEYE) that purchasers of FireEye securities between January 2, 2014 and November 4, 2014, have until January 26, 2015, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Northern District of California.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against FireEye, Inc. investment picks
Glancy Binkow & Goldberg LLP reminds investors of AcelRx Pharmaceuticals, Inc. (“AcelRx” or the “Company”) (NASDAQ: ACRX) that those who purchased or otherwise acquired AcelRx’s common stock and/or call options, or sold/wrote AcelRx’s put options between December 2, 2013 and September 25, 2014, inclusive (the “Class Period”), have until December 1, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Northern District of California.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. investment picks
Glancy Binkow & Goldberg LLP reminds investors of Enzymotec Ltd.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Enzymotec Ltd. investment picks
Glancy Binkow & Goldberg LLP reminds investors of PDL BioPharma, Inc. (“PDL BioPharma” or the “Company”) (NASDAQ:PDLI) that those who purchased or otherwise acquired PDL BioPharma securities between November 6, 2013 and September 16, 2014, inclusive (the “Class Period”), have until November 17, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the District of Nevada.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against PDL BioPharma, Inc. investment picks
2014/11/24
Glancy Binkow & Goldberg LLP reminds investors of Willbros Group, Inc. (“Willbros” or the “Company”) (NYSE:WG) that purchasers of Willbros securities between August 4, 2014 and October 21, 2014, inclusive (the “Class Period”), have until December 29, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Southern District of Texas.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Willbros Group, Inc. investment picks
Glancy Binkow & Goldberg LLP reminds investors of ITT Educational Services Inc. (“ITT” or the “Company”) (NYSE:ESI) that purchasers of ITT securities between February 26, 2013 and September 18, 2014, inclusive (the “Class Period”), have until December 1, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Southern District of Indiana.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against ITT Educational Services Inc. investment picks
Glancy Binkow & Goldberg LLP reminds investors of Albany Molecular Research Inc. (“Albany Molecular” or the “Company”) (NASDAQ:AMRI) that purchasers of Albany Molecular common stock between August 5, 2014 and November 5, 2014, inclusive (the “Class Period”), have until January 12, 2015, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit Albany Molecular is a contract research and manufacturing company that provides integrated drug discovery, development and manufacturing services primarily in the United States, Europe and Asia.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Albany Molecular Research Inc. investment picks
Glancy Binkow & Goldberg LLP reminds investors of Arrowhead Research Corporation (“Arrowhead” or the “Company”) (NASDAQ:ARWR) that purchasers of Arrowhead common stock between August 12, 2014 and October 8, 2014, inclusive (the “Class Period”), have until December 9, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Central District of California.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Arrowhead Research Corporation investment picks
Glancy Binkow & Goldberg LLP reminds investors of Tesco PLC (“Tesco” or the “Company”) (OTC:TSCDY) that purchasers of Tesco American Depositary Shares (“ADSs”) between January 9, 2014 and October 22, 2014, inclusive (the “Class Period”), have until December 22, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Southern District of New York.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Tesco PLC investment picks
Glancy Binkow & Goldberg LLP reminds investors of Retrophin, Inc. (“Retrophin” or the “Company”) (NASDAQ:RTRX) that purchasers of Retrophin securities between March 27, 2014 and September 30, 2014, inclusive (the “Class Period”), have until December 19, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Southern District of California.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Retrophin, Inc. investment picks
Glancy Binkow & Goldberg LLP reminds investors of Barrett Business Services, Inc. (“Barrett Business Services” or the “Company”) (NASDAQ:BBSI) that purchasers of Barrett Business Services securities between February 12, 2013 and October 29, 2014, inclusive (the “Class Period”), have until January 5, 2015, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Western District of Washington.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Barrett Business Services Inc. investment picks
Glancy Binkow & Goldberg LLP reminds investors of Aeterna Zentaris Inc. (“Aeterna” or the “Company”) (NASDAQ:AEZS) that purchasers of Aeterna securities between October 18, 2012 and November 5, 2014, inclusive (the “Class Period”), have until January 12, 2015, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the District of New Jersey.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Aeterna Zentaris Inc. investment picks
The Wagner Firm reminds investors of Albany Molecular Research Inc. (“Albany Molecular” or the “Company”) (NASDAQ:AMRI) that purchasers of Albany Molecular common stock between August 5, 2014 and November 5, 2014, inclusive (the “Class Period”), have until January 12, 2015, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit.
Sign-up for INVESTOR ALERT: The Wagner Firm Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit against Albany Molecular Research Inc. investment picks
Glancy Binkow & Goldberg LLP reminds investors of Rayonier, Inc. (“Rayonier” or the “Company”) (NYSE:RYN) that purchasers of Rayonier securities between January 27, 2014 and November 7, 2014, inclusive (the “Class Period”), have until January 12, 2015, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Middle District of Florida.
Sign-up for INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Rayonier, Inc. investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Reminded Investors
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Remind Shareholders  |  Next: Renewable Energy